dc.contributor.author |
Subbaiah, C S |
|
dc.contributor.author |
Haq, W |
|
dc.date.accessioned |
2014-11-14T07:16:30Z |
|
dc.date.available |
2014-11-14T07:16:30Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
Tetrahedron: Asymmetry,2014, 25(13–14), 1026–1030 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/1420 |
|
dc.description.abstract |
Synthesis of sitagliptin phosphate 1, a novel DPP-IV inhibitor for the treatment of type 2 diabetes mellitus has been accomplished starting from chiral synthon (1,4-bis[(R)-1-phenylethyl]piperazine-2,5-dione) 2, involving high stereocontrolled (>98%) alkylation as a key step, in a good overall yield of 50% over six steps. |
en |
dc.format.extent |
232169 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.relation.ispartofseries |
CSIR-CDRI Communication No. 8710 |
en |
dc.subject |
Sitagliptin phosphate |
en |
dc.subject |
Type 2 diabetes mellitus |
en |
dc.subject |
Stereocontrolled alkylation |
en |
dc.subject |
Asymmetric synthesis |
en |
dc.title |
Efficient Stereocontrolled Synthesis of Sitagliptin Phosphate |
en |
dc.type |
Article |
en |